Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-14
DOI
10.3389/fimmu.2016.00500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
- (2016) Thierry Burnouf et al. BIOMATERIALS
- Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
- (2016) R J O'Reilly et al. BONE MARROW TRANSPLANTATION
- TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
- (2016) M Maschan et al. BONE MARROW TRANSPLANTATION
- Haploidentical HCT using an αβ T-cell-depleted graft with targeted αβ+ cells by add-back after a reduced intensity preparative regimen containing low-dose TBI
- (2016) H J Im et al. BONE MARROW TRANSPLANTATION
- Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease and cancer
- (2016) R B Birge et al. CELL DEATH AND DIFFERENTIATION
- International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
- (2016) Jacques Galipeau et al. CYTOTHERAPY
- Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells
- (2016) Patrick Wuchter et al. EXPERIMENTAL HEMATOLOGY
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Surface Phosphatidylserine Is Responsible for the Internalization on Microvesicles Derived from Hypoxia-Induced Human Bone Marrow Mesenchymal Stem Cells into Human Endothelial Cells
- (2016) Xiaojuan Wei et al. PLoS One
- Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment
- (2016) A. Chiereghin et al. Transplant Infectious Disease
- Cytomegalovirus-Specific T Cells Isolated by IFN-γ Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro
- (2016) Marsela Qesari et al. TRANSPLANTATION
- Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy
- (2016) Oliver W. Gramlich et al. Scientific Reports
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy
- (2016) Samantha F. H. de Witte et al. Frontiers in Immunology
- Serum-free cell culture: the serum-free media interactive online database
- (2016) Daniel Brunner ALTEX-Alternatives to Animal Experimentation
- Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
- (2015) Laura Spring et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia
- (2015) Guenther Koehne et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunomodulation Effects of Mesenchymal Stromal Cells on Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation
- (2015) Ke Zhao et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
- (2015) J. Feucht et al. BLOOD
- T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR- +/CD19+ lymphocytes
- (2015) I. Airoldi et al. BLOOD
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- T-cell depletion: from positive selection to negative depletion in adult patients
- (2015) F Aversa BONE MARROW TRANSPLANTATION
- Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients
- (2015) P Lang et al. BONE MARROW TRANSPLANTATION
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Towards a commercial process for the manufacture of genetically modified T cells for therapy
- (2015) A D Kaiser et al. CANCER GENE THERAPY
- Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment
- (2015) Maria Raffaella Petrara et al. CANCER LETTERS
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- Induction of Regulatory B-Cells by Mesenchymal Stem Cells is Affected by SDF-1α-CXCR7
- (2015) Yan Qin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications
- (2015) Patrick Wuchter et al. CYTOTHERAPY
- Addition of varicella zoster virus–specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation
- (2015) Chun K.K. Ma et al. CYTOTHERAPY
- Selection of adenovirus-specific and Epstein-Barr virus–specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)–compliant conditions
- (2015) Christine Freimüller et al. CYTOTHERAPY
- Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
- (2015) Enrica Favaro et al. DIABETOLOGIA
- Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration
- (2015) Yoshihiro Nakamura et al. FEBS LETTERS
- T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect
- (2015) C. R. Cruz et al. HAEMATOLOGICA
- CAR therapy: the CD19 paradigm
- (2015) Michel Sadelain JOURNAL OF CLINICAL INVESTIGATION
- Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
- (2015) Marie Bleakley et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury
- (2015) Yanlu Zhang et al. JOURNAL OF NEUROSURGERY
- LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b
- (2015) Dongdong Ti et al. Journal of Translational Medicine
- Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
- (2015) Kevin J Curran et al. MOLECULAR THERAPY
- Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
- (2015) Sweta Rani et al. MOLECULAR THERAPY
- Hurdles in therapy with regulatory T cells
- (2015) Piotr Trzonkowski et al. Science Translational Medicine
- Bone Marrow-Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo
- (2015) Shoba Amarnath et al. STEM CELLS
- Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
- (2015) Donald G. Phinney et al. Nature Communications
- MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation
- (2015) Luciana De Luca et al. Oncotarget
- Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species
- (2015) Serena Rubina Baglio et al. Stem Cell Research & Therapy
- T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect
- (2015) C. R. Cruz et al. HAEMATOLOGICA
- Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications
- (2015) Marta E. Castro-Manrreza et al. Journal of Immunology Research
- Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
- (2015) Pappanaicken Kumaresan et al. Jove-Journal of Visualized Experiments
- Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis
- (2015) Jia Yang et al. PLoS One
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
- (2014) Fermín Sánchez-Guijo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
- (2014) Y. Xu et al. BLOOD
- Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells
- (2014) S. Gill et al. BLOOD
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
- (2014) P. Dreger et al. BLOOD
- Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
- (2014) Shannon L. Maude et al. CANCER JOURNAL
- Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions
- (2014) Sanjay Gottipamula et al. CELL AND TISSUE RESEARCH
- Clinical-scale isolation of ‘minimally manipulated’ cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease
- (2014) Marcus Odendahl et al. CYTOTHERAPY
- Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes
- (2014) Enrica Favaro et al. DIABETOLOGIA
- Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
- (2014) Saar Gill et al. IMMUNOLOGICAL REVIEWS
- Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway
- (2014) Y.-P. Li et al. JOURNAL OF IMMUNOLOGY
- T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells
- (2014) Géraldine Gallot et al. JOURNAL OF IMMUNOTHERAPY
- First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation
- (2014) René Geyeregger et al. JOURNAL OF IMMUNOTHERAPY
- MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
- (2014) L Kordelas et al. LEUKEMIA
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
- (2014) A. Papadopoulou et al. Science Translational Medicine
- Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
- (2014) Guido Moll et al. STEM CELLS
- Microvescicles Derived from Mesenchymal Stromal Cells Are Not as Effective as Their Cellular Counterpart in the Ability to Modulate Immune Responses In Vitro
- (2014) Antonella Conforti et al. STEM CELLS AND DEVELOPMENT
- Bone Marrow Mesenchymal Stromal Cells to Treat Complications Following Allogeneic Stem Cell Transplantation
- (2014) Minoo Battiwalla et al. TISSUE ENGINEERING PART B-REVIEWS
- Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
- (2014) Raquel Gomez-Eerland et al. Human Gene Therapy Methods
- Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells
- (2014) Rebeca Blazquez et al. Frontiers in Immunology
- Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy
- (2013) Yamei Wu et al. ANNALS OF HEMATOLOGY
- Current methods for the isolation of extracellular vesicles
- (2013) Fatemeh Momen-Heravi et al. BIOLOGICAL CHEMISTRY
- Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients
- (2013) Martino Introna et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
- (2013) Joanne Kurtzberg et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
- (2013) E. Blyth et al. BLOOD
- Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells
- (2013) Georg Siegel et al. BMC Medicine
- The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT
- (2013) A Marek et al. BONE MARROW TRANSPLANTATION
- Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease
- (2013) Lynne M. Ball et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation
- (2013) Waseem Qasim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
- (2013) Anna Casati et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives
- (2013) Xiaoting Liang et al. CELL TRANSPLANTATION
- Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture
- (2013) Michael Apel et al. CHEMIE INGENIEUR TECHNIK
- Simplified process for the production of anti–CD19-CAR–engineered T cells
- (2013) Barbara Tumaini et al. CYTOTHERAPY
- A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
- (2013) M. M. van Loenen et al. HAEMATOLOGICA
- Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
- (2013) Joseph G. Crompton et al. IMMUNOLOGICAL REVIEWS
- Relapsed childhood acute lymphoblastic leukaemia
- (2013) Deepa Bhojwani et al. LANCET ONCOLOGY
- Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
- (2013) Ulrike Gerdemann et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: Successful engraftment and mild GVHD
- (2013) Yamei Wu et al. Stem Cell Research
- Mesenchymal Stem Cells Secrete Immunologically Active Exosomes
- (2013) Bin Zhang et al. STEM CELLS AND DEVELOPMENT
- Platelet Lysate as Replacement for Fetal Bovine Serum in Mesenchymal Stromal Cell Cultures
- (2013) Karen Bieback TRANSFUSION MEDICINE AND HEMOTHERAPY
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
- (2012) H. Torikai et al. BLOOD
- Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
- (2012) M. J. Goldstein et al. CANCER RESEARCH
- Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
- (2012) M. Uhlin et al. CLINICAL INFECTIOUS DISEASES
- Microvesicles derived from mesenchymal stem cells: Potent organelles for induction of tolerogenic signaling
- (2012) Aram Mokarizadeh et al. IMMUNOLOGY LETTERS
- Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer
- (2012) Thomas Decker et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Comparative Outcomes of Donor Graft CD34+Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
- (2012) Marcelo C. Pasquini et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IL-10-Dependent Regulatory Dendritic Cells by SOCS3 Activation
- (2012) X. Liu et al. JOURNAL OF IMMUNOLOGY
- Sorting Through Subsets
- (2012) Christopher A. Klebanoff et al. JOURNAL OF IMMUNOTHERAPY
- Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines
- (2012) Pauline Meij et al. JOURNAL OF IMMUNOTHERAPY
- Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections
- (2012) Lei Bao et al. JOURNAL OF IMMUNOTHERAPY
- Identification and proteomic profiling of exosomes in human cerebrospinal fluid
- (2012) Jonathan M Street et al. Journal of Translational Medicine
- Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
- (2012) Ulrike Gerdemann et al. MOLECULAR THERAPY
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
- (2012) Manoj M. Lalu et al. PLoS One
- Transfer of Growth Factor Receptor mRNA Via Exosomes Unravels the Regenerative Effect of Mesenchymal Stem Cells
- (2012) Susanna Tomasoni et al. STEM CELLS AND DEVELOPMENT
- Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation
- (2012) Giovanna Lucchini et al. Stem Cells International
- Application of MultiStem® Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease
- (2012) Bart Vaes et al. Frontiers in Immunology
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
- (2012) E. Eggenhofer et al. Frontiers in Immunology
- Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages
- (2011) O. Ringden et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303
- (2011) Steven M. Devine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
- (2011) Lena von Bahr et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
- (2011) S. Terakura et al. BLOOD
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154
- (2011) N. Khanna et al. BLOOD
- Risk factors for acute GVHD and survival after hematopoietic cell transplantation
- (2011) M. Jagasia et al. BLOOD
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- The MSC: An Injury Drugstore
- (2011) Arnold I. Caplan et al. Cell Stem Cell
- Stem Cell Transplantation in Amyotrophic Lateral Sclerosis Patients: Methodological Approach, Safety, and Feasibility
- (2011) Héctor R. Martínez et al. CELL TRANSPLANTATION
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
- (2011) Bence György et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
- (2011) Moïra François et al. CYTOTHERAPY
- Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial
- (2011) J. A. Perez-Simon et al. HAEMATOLOGICA
- Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study
- (2011) Richard Herrmann et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Proteomic Analysis of Microvesicles Derived from Human Mesenchymal Stem Cells
- (2011) Han-Soo Kim et al. JOURNAL OF PROTEOME RESEARCH
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury
- (2011) S. Gatti et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia
- (2011) J. R. Brown Hematology-American Society of Hematology Education Program
- Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease—A Phase II Study
- (2011) Larisa A. Kuzmina et al. Stem Cells International
- Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning
- (2010) Frédéric Baron et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population
- (2010) Giovanna Lucchini et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
- (2010) Nathan Cantoni et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
- (2010) Vinod K. Prasad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
- (2010) J. N. Barker et al. BLOOD
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
- (2010) C. S. Hinrichs et al. BLOOD
- Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
- (2010) J. J. Melenhorst et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
- (2010) T. Feuchtinger et al. BLOOD
- Allo-HLA reactivity of virus-specific memory T cells is common
- (2010) A. L. Amir et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability
- (2010) Ruben Crespo-Diaz et al. CELL TRANSPLANTATION
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database
- (2010) Dimitrios P. Kontoyiannis et al. CLINICAL INFECTIOUS DISEASES
- Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
- (2010) K. S. Peggs et al. CLINICAL INFECTIOUS DISEASES
- Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy
- (2010) Lamia Aïssi-Rothé et al. JOURNAL OF IMMUNOTHERAPY
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Cross-Reactivity of Herpesvirus-Specific CD8 T Cell Lines Toward Allogeneic Class I MHC Molecules
- (2010) Alexis Morice et al. PLoS One
- Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
- (2010) Ruenn Chai Lai et al. Stem Cell Research
- Mesenchymal Stem Cells Inhibit Complement Activation by Secreting Factor H
- (2010) Zhidan Tu et al. STEM CELLS AND DEVELOPMENT
- Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
- (2010) Anita Schmitt et al. TRANSFUSION
- Alloreactivity from human viral specific memory T-cells
- (2010) L.J.A D'Orsogna et al. TRANSPLANT IMMUNOLOGY
- Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
- (2009) A. M. Leen et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions
- (2009) C C Dvorak et al. BONE MARROW TRANSPLANTATION
- Cell contact, prostaglandin E2and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+regulatory T cells
- (2009) K. English et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunobiology of Human Cytomegalovirus: from Bench to Bedside
- (2009) T. Crough et al. CLINICAL MICROBIOLOGY REVIEWS
- Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages
- (2009) Jaehyup Kim et al. EXPERIMENTAL HEMATOLOGY
- CMV-Specific TCR-Transgenic T Cells for Immunotherapy
- (2009) A. Schub et al. JOURNAL OF IMMUNOLOGY
- C3a and C5a Are Chemotactic Factors for Human Mesenchymal Stem Cells, Which Cause Prolonged ERK1/2 Phosphorylation
- (2009) I. U. Schraufstatter et al. JOURNAL OF IMMUNOLOGY
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs
- (2009) Tian Sheng Chen et al. NUCLEIC ACIDS RESEARCH
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational development of high-affinity T-cell receptor-like antibodies
- (2009) G. Stewart-Jones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal stem cells for clinical application
- (2009) L. Sensebé et al. VOX SANGUINIS
- Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population
- (2008) B. Zhang et al. BLOOD
- Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT
- (2008) B Pourgheysari et al. BONE MARROW TRANSPLANTATION
- Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
- (2008) M von Bonin et al. BONE MARROW TRANSPLANTATION
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
- The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
- (2008) H Ning et al. LEUKEMIA
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells
- (2007) Stephen Mackinnon et al. BLOOD CELLS MOLECULES AND DISEASES
- Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+Regulatory T Cells
- (2007) Zohair Selmani et al. STEM CELLS
- Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche
- (2007) Lizzia Raffaghello et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started